GREG HALLIDAY: Open Payments
NPI 1366431918 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 28 payments from 7 companies in 2025. Trend: 2023 $803 · 2024 $673 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $159 |
| E.R. Squibb & Sons, L.L.C. | 13 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: REPATHA, CAMZYOS, JARDIANCE, ELIQUIS, PRALUENT, AMVUTTRA, LEQVIO.
Industry payments across UT — which companies pay providers there.
